bezafibrate has been researched along with Hyperglycemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henke, BR | 1 |
| Adamski, J; Aichler, M; Baumann, M; Beckers, J; Dubois, G; Feuchtinger, A; Franko, A; Fuchs, H; Gradinger, D; Hrabě de Angelis, M; Huypens, P; Irmler, M; Massinger, R; Neff, F; Neschen, S; Peter, A; Prehn, C; Prokisch, H; Przemeck, GK; Rathkolb, B; Repp, B; Rozman, J; Sanchez-Lasheras, C; Schommers, P; Schubert, M; Stöhr, O; Walch, AK; Wiesner, RJ; Wolf, E | 1 |
| Hattori, S; Hattori, Y; Inoue, T; Kasai, K; Tomizawa, A | 1 |
| Kotake, H | 1 |
| Arnaout, A; Malcolm, J; Sigal, R | 1 |
| Alam, MM; Anwer, T; Haque, SE; Pillai, KK; Sharma, M; Zaman, MS | 1 |
| Arai, N; Ebihara, K; Hosoda, K; Inada, Y; Ishii, T; Maruyama, K; Masuzaki, H; Nakano, S; Nakao, K; Shibata, N; Tanaka, T; Yamazaki, Y; Yasue, S | 1 |
3 review(s) available for bezafibrate and Hyperglycemia
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2004 |
[Syndrome X].
Topics: Animals; Bezafibrate; Biguanides; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Leptin; Life Style; Metabolic Syndrome; Pioglitazone; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2002 |
Prevention of cardiovascular events in diabetes.
Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Bezafibrate; Cardiovascular Diseases; Clopidogrel; Diabetic Angiopathies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Smoking Cessation; Ticlopidine | 2006 |
4 other study(ies) available for bezafibrate and Hyperglycemia
| Article | Year |
|---|---|
Bezafibrate Improves Insulin Sensitivity and Metabolic Flexibility in STZ-Induced Diabetic Mice.
Topics: Animals; Bezafibrate; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Liver; Male; Metabolomics; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Oligonucleotide Array Sequence Analysis; Oxygen Consumption; Peroxisome Proliferator-Activated Receptors | 2016 |
Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation.
Topics: AMP-Activated Protein Kinases; Apoptosis; Bezafibrate; Blotting, Western; Capillaries; Cells, Cultured; Endothelial Cells; Enzyme Activation; Fenofibrate; Glycation End Products, Advanced; Hepatocytes; Humans; Hyperglycemia; Hypolipidemic Agents; I-kappa B Kinase; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type III; PPAR alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Vasculitis | 2011 |
Protective effect of bezafibrate on streptozotocin-induced oxidative stress and toxicity in rats.
Topics: Administration, Oral; Animals; Antioxidants; Bezafibrate; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase; Hyperglycemia; Hypolipidemic Agents; Injections, Intraperitoneal; Insulin-Secreting Cells; Islets of Langerhans; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase; Time Factors | 2007 |
Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 3T3-L1 Cells; Adipocytes; Adiponectin; Adipose Tissue; Animals; Bezafibrate; Diabetes Complications; Diabetes Mellitus; Fatty Acids, Nonesterified; Hyperglycemia; Hypolipidemic Agents; Insulin Resistance; Liver; Male; Mice; Mice, Inbred Strains; Organ Size; Oxidoreductases; Peroxisome Proliferator-Activated Receptors; RNA, Messenger; RNA, Small Interfering; Triglycerides | 2007 |